$4.37−0.04 (−0.79%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Alvotech (ALVO) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
1 figure withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~69.7%/yr (FY21→FY25), net margin 3.6%.
The four lines that matter · FY21–FY25
Revenue ($M)▲34.2%
778.5
FY21→FY25CAGR +69.7%/yr
Net income ($M)—
27.9
one-off year: see footnoteCAGR —
Free cash flow ($M)—
—
no FY25 valueCAGR —
Diluted EPS—
—
no FY25 valueCAGR —
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
4¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross -24.9% → 50.6%. Net margin 3.6% is above the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
On the latest annual statement the reported earnings per share does not reconcile with net income to common shareholders divided by the reported share count (a factor of 1.259), so the two figures are on different bases. Both are shown as filed.
USD millions except per-share & ratios
| Line item | FY25 † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 778.5 | 778.5 | 580.3 | 93.0 | 98.1 | 93.9 | ▲34.2% | +69.7% |
Cost of revenue | 384.7 | 384.7 | 488.5 | 428.0 | 252.5 | 117.4 | ▼21.2% | +34.6% |
Gross profit | 393.8 | 393.8 | 91.8 | −335.0 | −154.4 | −23.4 | ▲328.9% | — |
Research & development | 184.2 | 184.2 | 171.3 | 210.8 | 180.6 | 191.0 | ▲7.5% | −0.9% |
Selling, general & admin | 90.9 | 90.9 | 65.7 | 76.6 | 186.7 | 84.1 | ▲38.4% | +2.0% |
Total operating expenses | 275.1 | 275.1 | 237.0 | 308.9 | 367.4 | 275.1 | ▲16.1% | −0.0% |
Operating incomefeeds ROC rank | 118.6 | 118.6 | −145.2 | −643.9 | −521.7 | −298.6 | — | — |
Other income, net | 17.7 | 17.7 | −72.3 | −7.2 | −29.9 | 149.4 | — | — |
Pretax income | 136.3 | 136.3 | −217.6 | −651.0 | −551.6 | −149.2 | — | — |
Income tax | 108.4 | 108.4 | 14.3 | −99.3 | −38.1 | −47.7 | ▲658.2% | — |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 27.9 | 27.9 | −231.9 | −551.7 | −513.6 | −101.5 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | — | — | — | — | −2.60 | −0.92 | — | — |
Diluted shares (mn) | 312.02 | 312.02 | 301.81 | 266.82 | 248.65 | — | ▲3.4% | +7.9% |
| Margins | ||||||||
Gross margin29th pct in Healthcare | 50.6% | 50.6% | 15.8% | −360.1% | −157.3% | −24.9% | ▲34.8pp | +75.5pp |
Operating margin | 15.2% | 15.2% | −25.0% | −692.2% | −531.7% | −317.9% | ▲40.3pp | +333.1pp |
Net margin51st pct in Healthcare | 3.6% | 3.6% | −40.0% | −593.1% | −523.4% | −108.1% | ▲43.5pp | +111.6pp |
† FY25 = fiscal 2025, through 2025-12-31; the trailing year is not available.FY21 effective tax rate was 32% vs a 15% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 7% vs a 15% norm for this window, likely a one-time item; see the filing.
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-30 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Alvotech's revenue last fiscal year?
Alvotech reported revenue of $778.5M in fiscal 2025, up 34.2% from fiscal 2024.
What was Alvotech's net income?
Alvotech reported net income of $27.9M in fiscal 2025, a net margin of 3.6%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

